Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Chevalier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|June 23, 2005
Synthesis, physical properties, multitemperature crystal structure, and 20 K synchrotron X-ray charge density of a magnetic metal organic framework structure, Mn3(C8O4H4)3(C5H11ON)2Rasmus D Poulsen, Anders Bentien, Marie Chevalier, et al.
Diagnostics (Basel, Switzerland)|August 6, 2020
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and PyrosequencingAmandine Billaud, Veronique Verriele, Jonathan Dauvé, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Molecular Diagnosis & Therapy|March 4, 2020
Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP InhibitorsLouise-Marie Chevalier, Amandine Billaud, Sabrina Fronteau, et al.
Annales De Pathologie|February 22, 2020
[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies]Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, et al.
Genome Medicine|November 9, 2021
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genesAmandine Billaud, Louise-Marie Chevalier, Paule Augereau, et al.
Expert Opinion on Drug Safety|June 5, 2019
Benefits versus risk profile of buparlisib for the treatment of breast cancerAnne Patsouris, Paule Augereau, Jean-Sebastien Frenel, et al.
Bulletin Du Cancer|January 13, 2026
[Specificities of allogeneic stem cell transplantation for sickle cell disease (SFGM-TC)]Sarah Morin, Cécile Borel, Marie Chevalier, et al.
Cancer Immunology Research|January 12, 2020
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor PhenotypeLéa Paolini, Clément Adam, Céline Beauvillain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF TrialSéverine Guiu, Judith Balmaña, Pablo Lemercier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|June 23, 2005
Synthesis, physical properties, multitemperature crystal structure, and 20 K synchrotron X-ray charge density of a magnetic metal organic framework structure, Mn3(C8O4H4)3(C5H11ON)2Rasmus D Poulsen, Anders Bentien, Marie Chevalier, et al.
Diagnostics (Basel, Switzerland)|August 6, 2020
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and PyrosequencingAmandine Billaud, Veronique Verriele, Jonathan Dauvé, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Molecular Diagnosis & Therapy|March 4, 2020
Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP InhibitorsLouise-Marie Chevalier, Amandine Billaud, Sabrina Fronteau, et al.
Annales De Pathologie|February 22, 2020
[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies]Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, et al.
Genome Medicine|November 9, 2021
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genesAmandine Billaud, Louise-Marie Chevalier, Paule Augereau, et al.
Expert Opinion on Drug Safety|June 5, 2019
Benefits versus risk profile of buparlisib for the treatment of breast cancerAnne Patsouris, Paule Augereau, Jean-Sebastien Frenel, et al.
Bulletin Du Cancer|January 13, 2026
[Specificities of allogeneic stem cell transplantation for sickle cell disease (SFGM-TC)]Sarah Morin, Cécile Borel, Marie Chevalier, et al.
Cancer Immunology Research|January 12, 2020
Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor PhenotypeLéa Paolini, Clément Adam, Céline Beauvillain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF TrialSéverine Guiu, Judith Balmaña, Pablo Lemercier, et al.
Pageof 2